FACTORS ASSOCIATED WITH INITIATION OF BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN MOROCCAN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Hammou, O. [1 ]
Chennouf, F. [1 ]
Azzouzi, H. [1 ]
Linda, I. [1 ]
机构：
[1] Mohammed I Univ, Mohammed Univ Hosp 6, Dept Rheumatol, Oujda, Morocco
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.5633
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0293
引用
收藏
页码：1441 / 1441
页数：1
相关论文
共 50 条
  • [31] The Risk of Cardiovascular Events Associated With Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis
    Ozen, Gulsen
    Pedro, Sofia
    Michaud, Kaleb
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (05) : 648 - 655
  • [32] Disease-modifying antirheumatic drugs and bone mass in rheumatoid arthritis
    Di Munno, O
    Delle Sedie, A
    Rossini, A
    Adamil, S
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (02) : 137 - 144
  • [33] Efficacy, Tolerability and Cost Effectiveness of Disease-Modifying Antirheumatic Drugs and Biologic Agents in Rheumatoid Arthritis
    Michael T. Nurmohamed
    Ben A. C. Dijkmans
    Drugs, 2005, 65 : 661 - 694
  • [34] Conventional disease-modifying antirheumatic drugs to treat rheumatoid arthritis
    Rath, T.
    Sander, O.
    Rubbert, A.
    DRUG DEVELOPMENT RESEARCH, 2011, 72 (08) : 657 - 663
  • [35] Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis
    Emery, Paul
    Sebba, Anthony
    Huizinga, Tom W. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (12) : 1897 - 1904
  • [36] Safety of biological disease-modifying antirheumatic drugs in rheumatoid arthritis
    Martinez-Mugica, Cristina
    Salgueiro, Esther
    FARMACIA HOSPITALARIA, 2022, 46 (01) : 15 - 20
  • [37] Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis
    Nurmohamed, MT
    Dijkmans, BAC
    DRUGS, 2005, 65 (05) : 661 - 694
  • [38] Factors Associated with Initial or Subsequent Choice of Biologic Disease Modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis
    Jin, Yinzhu
    Desai, Rishi J.
    Liu, Jun
    Choi, Nam-Kyong
    Kim, Seoyoung
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [39] Drug retention of biologic and targeted synthetic disease-modifying antirheumatic drugs in Korean patients with seropositive rheumatoid arthritis
    Lee, Bong -Woo
    Lee, Jennifer Jooha
    Kim, Wan-Uk
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2024, 39 (05): : 833 - +
  • [40] DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARD) IN THE TREATMENT OF PATIENTS WITH RHEUMATOID-ARTHRITIS
    HALBERG, P
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1986, : 55 - 57
12345